Cytometry Part B: Clinical Cytometry最新文献

筛选
英文 中文
Immunophenotypic characteristics of plasma cells in POEMS syndrome POEMS综合征浆细胞的免疫表型特征。
IF 2.9 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-07-04 Epub Date: 2026-02-16 DOI: 10.1002/cytob.70012
Zhenhua Wang, Tianling Ding, Beiqian Wu, Qiang Niu, Leyao Gu, Yan Yuan, Ping Zhu
{"title":"Immunophenotypic characteristics of plasma cells in POEMS syndrome","authors":"Zhenhua Wang,&nbsp;Tianling Ding,&nbsp;Beiqian Wu,&nbsp;Qiang Niu,&nbsp;Leyao Gu,&nbsp;Yan Yuan,&nbsp;Ping Zhu","doi":"10.1002/cytob.70012","DOIUrl":"10.1002/cytob.70012","url":null,"abstract":"<p>To analyze the immunophenotypic characteristics of plasma cells in patients with polyneuropathy, organomegaly, endocrinopathy, myeloma protein, and skin changes (POEMS) syndrome. This retrospective study included patients with POEMS syndrome hospitalized in the Department of Hematology, Huashan Hospital, from September 2017 to August 2025. Demographic data, clinical features, flow cytometry results, and bone marrow morphological findings were analyzed. A total of 69 POEMS syndrome patients (44 males, 25 females; median age 54 years) were included. Flow cytometry detected monoclonal plasma cells in 63.77% (44/69) of patients, with higher plasma cell proportions in cases with detectable monoclonal plasma cells group (<i>p =</i> 0.003). The nine-color flow cytometry protocol demonstrated a significantly higher detection rate of monoclonal plasma cells compared to the six-color protocol (77.42% vs. 52.63%, <i>p =</i> 0.033). Immunophenotypic analysis revealed 100% expression of CD38 and CD138, with higher expression of CD27, CD28, CD117, and CD81 in POEMS patients compared to multiple myeloma patients (all <i>p &lt;</i> 0.05). Bone marrow morphology showed higher plasma cell proportions in the abnormal group (<i>p =</i> 0.01). With additional fluorescent channels and enhanced detection sensitivity offering simultaneous analysis of multiple surface markers and intracellular light chains (κ/λ), nine-color flow cytometry enables more precise identification of abnormal plasma cells in POEMS syndrome based on distinct marker expression profiles. CD27, CD28, and CD117 are recommended as potential immunomarkers for flow cytometric analysis in POEMS syndrome.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 4","pages":"266-273"},"PeriodicalIF":2.9,"publicationDate":"2026-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cytob.70012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146200480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on “An unusual pattern observed upon the addition of CD79b to a flow-Cytometry B-cell Lymphoma panel” (Cytometry B Clin Cytom. 2025 Jul 14. Doi: 10.1002/cyto.b.22246. Epub ahead of print. PMID: 40657818) 对“流式细胞术B细胞淋巴瘤检测中添加CD79b后观察到的异常模式”的评论(《细胞术B细胞》,2025年7月14日)。Doi: 10.1002 / cyto.b.22246。打印前Epub。PMID: 40657818)。
IF 2.9 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-07-04 Epub Date: 2025-11-25 DOI: 10.1002/cytob.70000
Aaruni Khanolkar, Aisha Ahmed
{"title":"Comment on “An unusual pattern observed upon the addition of CD79b to a flow-Cytometry B-cell Lymphoma panel” (Cytometry B Clin Cytom. 2025 Jul 14. Doi: 10.1002/cyto.b.22246. Epub ahead of print. PMID: 40657818)","authors":"Aaruni Khanolkar,&nbsp;Aisha Ahmed","doi":"10.1002/cytob.70000","DOIUrl":"10.1002/cytob.70000","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 4","pages":"297-298"},"PeriodicalIF":2.9,"publicationDate":"2026-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145602939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Signal without noise: Practical antibody titration for platelet flow cytometry 无噪声信号:用于血小板流式细胞术的实用抗体滴定。
IF 2.9 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-07-04 Epub Date: 2025-12-19 DOI: 10.1002/cytob.70004
Benjamin E. J. Spurgeon
{"title":"Signal without noise: Practical antibody titration for platelet flow cytometry","authors":"Benjamin E. J. Spurgeon","doi":"10.1002/cytob.70004","DOIUrl":"10.1002/cytob.70004","url":null,"abstract":"<p>Antibody titration is essential for optimizing platelet flow cytometry, a technique widely used to evaluate platelet phenotype, activation status, and function. This manuscript outlines practical approaches for platelet antibody titration in whole blood, with tailored strategies for constitutive and inducible markers. It emphasizes the use of appropriate controls, consideration of marker coexpression, and selection of subsaturating antibody concentrations to maximize signal resolution while minimizing background and artifactual activation. Quantitative metrics such as the stain index and separation index are introduced as tools for evaluating staining performance. The discussion also addresses key technical variables, including combinatorial titration, spillover spreading, lot variability, and antibody-induced activation. Titration under final assay conditions is recommended to ensure reproducibility and biological relevance. These strategies provide a foundation for developing robust, high-resolution platelet assays that support both research and clinical applications, particularly as flow cytometry evolves toward greater automation and standardization.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 4","pages":"240-248"},"PeriodicalIF":2.9,"publicationDate":"2026-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145780612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishing a flow cytometry-based tissue receptor occupancy assay for an anti-oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel disease 建立一种基于流式细胞术的组织受体占用试验,用于炎症性肠病的抗肿瘤抑制素M受体β亚基治疗候选物。
IF 2.9 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-07-04 Epub Date: 2026-03-23 DOI: 10.1002/cyto.b.70025
Divya Jha, Hailey Garma, Sean Lear, Aaron Schroeder, Olusegun Onabajo, Franklin Fuh, William E. O'Gorman, Matthew D. Taylor, Jacqueline McBride, Margaret Neighbors, Saurabh Mehandru
{"title":"Establishing a flow cytometry-based tissue receptor occupancy assay for an anti-oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel disease","authors":"Divya Jha,&nbsp;Hailey Garma,&nbsp;Sean Lear,&nbsp;Aaron Schroeder,&nbsp;Olusegun Onabajo,&nbsp;Franklin Fuh,&nbsp;William E. O'Gorman,&nbsp;Matthew D. Taylor,&nbsp;Jacqueline McBride,&nbsp;Margaret Neighbors,&nbsp;Saurabh Mehandru","doi":"10.1002/cyto.b.70025","DOIUrl":"10.1002/cyto.b.70025","url":null,"abstract":"<p>This article details the development of a tissue-based receptor occupancy (RO) assay using colonic pinch biopsies to enable the evaluation of vixarelimab target coverage in a Phase 1c study for inflammatory bowel disease (IBD). Vixarelimab, a monoclonal antibody targeting Oncostatin M Receptor Beta subunit (OSMRβ), has demonstrated clinical efficacy in treating inflammatory conditions such as prurigo nodularis and chronic pruritus. It was more recently studied in patients with ulcerative colitis (UC). Understanding the drug's distribution and retention in gut tissues is essential for assessing its therapeutic potential for IBD. While RO assays are powerful tools for evaluating drug target engagement, there are gaps in best practices for their development, especially when applied to sample types not readily available as single-cell suspensions. This article addresses challenges associated with tissue processing, cell recovery, and accurate interpretation of RO results, offering insights into overcoming limitations in sample availability and variability in drug-target interactions during assay development.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 4","pages":"274-287"},"PeriodicalIF":2.9,"publicationDate":"2026-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147497614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issue highlights—July 2026 问题亮点- 2026年7月
IF 2.9 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-07-04 DOI: 10.1002/cyto.b.70049
{"title":"Issue highlights—July 2026","authors":"","doi":"10.1002/cyto.b.70049","DOIUrl":"https://doi.org/10.1002/cyto.b.70049","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 4","pages":"237-239"},"PeriodicalIF":2.9,"publicationDate":"2026-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148386618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To fret over FRET: Unintended fluorescence energy transfer artifacts and their implications for flow cytometry panel design and interpretation as highlighted by TRBC1/2 assays 担心fret:意想不到的荧光能量转移伪影及其对流式细胞仪面板设计和解释的影响,如TRBC1/2测定所强调的那样。
IF 2.9 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-07-04 Epub Date: 2026-04-08 DOI: 10.1002/cyto.b.70032
Hao-Wei Wang, Dana Delgado Colon, Kyle Murphy, Richard R. Sochacki, Robert Honec, Jacob Wellek, Isabella Bristol, Jung Jang, Truc Ho, Mariela Monreal, Constance M. Yuan
{"title":"To fret over FRET: Unintended fluorescence energy transfer artifacts and their implications for flow cytometry panel design and interpretation as highlighted by TRBC1/2 assays","authors":"Hao-Wei Wang,&nbsp;Dana Delgado Colon,&nbsp;Kyle Murphy,&nbsp;Richard R. Sochacki,&nbsp;Robert Honec,&nbsp;Jacob Wellek,&nbsp;Isabella Bristol,&nbsp;Jung Jang,&nbsp;Truc Ho,&nbsp;Mariela Monreal,&nbsp;Constance M. Yuan","doi":"10.1002/cyto.b.70032","DOIUrl":"10.1002/cyto.b.70032","url":null,"abstract":"<p>Förster resonance energy transfer (FRET) serves as the fundamental mechanism underlying a wide array of technologies employed in biomedical research and clinical diagnostic applications. However, unintended FRET is often overlooked, despite its potential to introduce assay artifacts that may lead to misinterpretation. Here, we examine the impact of unwanted FRET on clinical flow cytometric testing, focusing on the T-cell assay incorporating TRBC1 and TRBC2, which has emerged as a powerful method for assessing T-cell clonality. We illustrated the effect using a representative case of spurious antigen expression associated with false TRBC restriction and demonstrate through control experiments that this artifact arises when target antigens in close proximity are labeled with fluorochromes having overlapping spectra. We quantified the spectral overlap integral J(λ), and generated a matrix for commonly used fluorochromes, providing a practical tool to identify fluorochrome pairs with a high FRET propensity that should be avoided when labeling closely situated antigens. Overall, recognizing the potential effects of unintended FRET and implementing strategies to prevent or minimize its impact are essential for ensuring accurate interpretation of clinical flow cytometric assays.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 4","pages":"249-258"},"PeriodicalIF":2.9,"publicationDate":"2026-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147638178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' Response to Letter from Khanolkar and Ahmed concerning our article “An unusual pattern observed upon the addition of CD79b to a flow cytometry B-cell lymphoma panel” (Panakkal et al., 2025). Cytometry Part B: Clinical Cytometry. DOI: 10.1002/cyto.b.22246. PMID: 40657818 作者对Khanolkar和Ahmed关于我们的文章“在流式细胞术b细胞淋巴瘤面板中添加CD79b观察到的不寻常模式”的来信的回复(Panakkal et al., 2025)。细胞术B部分:临床细胞术。DOI: 10.1002 / cyto.b.22246。PMID: 40657818。
IF 2.9 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-07-04 Epub Date: 2025-12-25 DOI: 10.1002/cytob.70005
Vandana Panakkal, Raniah Al Amri, Stacey Mamatas, Sara A. Monaghan, Ahmad Al-Attar
{"title":"Authors' Response to Letter from Khanolkar and Ahmed concerning our article “An unusual pattern observed upon the addition of CD79b to a flow cytometry B-cell lymphoma panel” (Panakkal et al., 2025). Cytometry Part B: Clinical Cytometry. DOI: 10.1002/cyto.b.22246. PMID: 40657818","authors":"Vandana Panakkal,&nbsp;Raniah Al Amri,&nbsp;Stacey Mamatas,&nbsp;Sara A. Monaghan,&nbsp;Ahmad Al-Attar","doi":"10.1002/cytob.70005","DOIUrl":"10.1002/cytob.70005","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 4","pages":"299-300"},"PeriodicalIF":2.9,"publicationDate":"2026-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145827158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapy-related B-lymphoblastic leukemia/lymphoma with MYC rearrangement and multisite involvement following chemotherapy for ovarian cancer 卵巢癌化疗后伴有MYC重排和多部位累及的治疗相关性b淋巴细胞白血病/淋巴瘤
IF 2.9 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-07-04 Epub Date: 2026-01-30 DOI: 10.1002/cytob.70013
Gailing Zhang, Man Chen, Ting Li, Ping Wu, Lina Zhang, Aixian Wang, Hui Wang
{"title":"Therapy-related B-lymphoblastic leukemia/lymphoma with MYC rearrangement and multisite involvement following chemotherapy for ovarian cancer","authors":"Gailing Zhang,&nbsp;Man Chen,&nbsp;Ting Li,&nbsp;Ping Wu,&nbsp;Lina Zhang,&nbsp;Aixian Wang,&nbsp;Hui Wang","doi":"10.1002/cytob.70013","DOIUrl":"10.1002/cytob.70013","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 4","pages":"305-308"},"PeriodicalIF":2.9,"publicationDate":"2026-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantifying interpretive contributions to analytical variability in clinical flow cytometry. 定量解释对临床流式细胞术分析变异性的贡献。
IF 2.9 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-06-21 DOI: 10.1002/cyto.b.70048
Paul E Mead, Baptiste Labarthe, Christy Embrey, Jeffery M Klco, Kamila Czechowska
{"title":"Quantifying interpretive contributions to analytical variability in clinical flow cytometry.","authors":"Paul E Mead, Baptiste Labarthe, Christy Embrey, Jeffery M Klco, Kamila Czechowska","doi":"10.1002/cyto.b.70048","DOIUrl":"https://doi.org/10.1002/cyto.b.70048","url":null,"abstract":"<p><p>Reproducibility in clinical flow cytometry is essential for diagnosis, longitudinal monitoring, and interlaboratory harmonization, particularly when threshold-based lymphocyte measurements such as absolute CD4 counts guide clinical management. Although standardization of instruments, reagents, antibody panels, and acquisition protocols has reduced variability at the level of signal generation, variability introduced by human interpretation during manual gating has not been quantitatively separated from biological and technical sources. Here, we applied a two-stage workflow audit anchored to a fixed, invariant automated analysis used as an analytical reference to quantify interpretive variability in routine clinical TBNK (T-cell, B-cell, and natural killer cell) flow cytometry and to assess its impact on CD4 decision-band classification. Standardized quality-control materials and 320 consecutive clinical samples, independently analyzed by six technologists on three harmonized cytometers, were used to define an empirical analytical performance envelope (i.e., the expected range of performance) and to evaluate departures from this envelope under routine conditions. Under quality-control conditions, automated-manual differences were stable and interpretable: percentage-based endpoints showed near-zero bias with narrow dispersion, absolute counts exhibited small, consistent offsets, and CD4 decision-band assignment was preserved. In contrast, routine clinical samples showed substantially greater dispersion that was structured primarily by operator identity rather than instrument configuration. Operator-associated disagreement exceeded instrument-associated variability, was low dimensional and reproducible, and was concentrated near established CD4 thresholds, yielding discordant but adjacent decision-band classifications. These findings quantify a previously unmeasured source of analytical variability in routine hematology testing that can affect threshold-based clinical classification despite acceptable quality-control performance.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148293799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantifying gating heterogeneity in the Ogata score: Implications for reproducibility and score-based diagnostics. 量化门控异质性在绪方评分:再现性和基于评分的诊断的含义。
IF 2.9 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-06-20 DOI: 10.1002/cyto.b.70047
Marc Sorigue, Milos Miljkovic, Jordi Petriz
{"title":"Quantifying gating heterogeneity in the Ogata score: Implications for reproducibility and score-based diagnostics.","authors":"Marc Sorigue, Milos Miljkovic, Jordi Petriz","doi":"10.1002/cyto.b.70047","DOIUrl":"https://doi.org/10.1002/cyto.b.70047","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148293810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书